Endo Trustee Sues McKinsey Over ‘Reckless’ Opioid Sales Advice

Aug. 16, 2024, 4:50 PM UTC

Consulting giant McKinsey & Co. should pay for the harm it caused pharmaceutical maker Endo International Plc through its “reckless” advice on marketing and selling opioids, a bankruptcy plan trustee said in a lawsuit.

The suit, filed Thursday in the US Bankruptcy Court for the Southern District of New York, is brought on behalf of a trust created to pay unsecured creditors of Endo and its affiliates. Endo in March won court approval of a Chapter 11 plan that resolved its major opioid liabilities and handed the company to its lenders.

The trustee accuses McKinsey and its affiliates of ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.